Van Groeningen CJ - Search Results

1

Pharmacokinetics of bolus 5-fluorouracil: relationship between dose, plasma concentrations, area-under-the-curve and toxicity.

Codacci-Pisanelli G, Pinedo HM, Lankelma J, Van Groeningen CJ, Van Kuilenburg AB, Van Gennip AH, Peters GJ. Codacci-Pisanelli G, et al. Among authors: van gennip ah, van groeningen cj, van kuilenburg ab. J Chemother. 2005 Jun;17(3):315-20. doi: 10.1179/joc.2005.17.3.315. J Chemother. 2005. PMID: 16038526 Clinical Trial.

2

Clinical relevance of biochemical modulation of 5-fluorouracil.

Peters GJ, van Groeningen CJ. Peters GJ, et al. Among authors: van groeningen cj. Ann Oncol. 1991 Jul;2(7):469-80. doi: 10.1093/oxfordjournals.annonc.a057994. Ann Oncol. 1991. PMID: 1911453 Free article. Review.

3

Lack of effectiveness of combined 5-fluorouracil and leucovorin in patients with 5-fluorouracil-resistant advanced colorectal cancer.

van Groeningen CJ, Peters GJ, Pinedo HM. van Groeningen CJ, et al. Eur J Cancer Clin Oncol. 1989 Jan;25(1):45-9. doi: 10.1016/0277-5379(89)90049-7. Eur J Cancer Clin Oncol. 1989. PMID: 2784100

4

Schedule-dependency of in vivo modulation of 5-fluorouracil by leucovorin and uridine in murine colon carcinoma.

Nadal JC, van Groeningen CJ, Pinedo HM, Peters GJ. Nadal JC, et al. Among authors: van groeningen cj. Invest New Drugs. 1989 Jul;7(2-3):163-72. doi: 10.1007/BF00170853. Invest New Drugs. 1989. PMID: 2793368

5

Reversal of 5-fluorouracil-induced myelosuppression by prolonged administration of high-dose uridine.

van Groeningen CJ, Peters GJ, Leyva A, Laurensse E, Pinedo HM. van Groeningen CJ, et al. J Natl Cancer Inst. 1989 Jan 18;81(2):157-62. doi: 10.1093/jnci/81.2.157. J Natl Cancer Inst. 1989. PMID: 2909757

6

Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer.

Peters GJ, Van Dijk J, Nadal JC, Van Groeningen CJ, Lankelma J, Pinedo HM. Peters GJ, et al. Among authors: van groeningen cj, van dijk j. In Vivo. 1987 Mar-Apr;1(2):113-7. In Vivo. 1987. PMID: 2979771

7

In vivo potentiation of 5-fluorouracil by leucovorin in murine colon carcinoma.

Nadal JC, Van Groeningen CJ, Pinedo HM, Peters GJ. Nadal JC, et al. Among authors: van groeningen cj. Biomed Pharmacother. 1988;42(6):387-93. Biomed Pharmacother. 1988. PMID: 3064823 Review.

8

Pharmacokinetics of 5-fluorouracil assessed with a sensitive mass spectrometric method in patients on a dose escalation schedule.

van Groeningen CJ, Pinedo HM, Heddes J, Kok RM, de Jong AP, Wattel E, Peters GJ, Lankelma J. van Groeningen CJ, et al. Cancer Res. 1988 Dec 1;48(23):6956-61. Cancer Res. 1988. PMID: 3180104

9

Uridine-induced hypothermia in mice and rats in relation to plasma and tissue levels of uridine and its metabolites.

Peters GJ, van Groeningen CJ, Laurensse EJ, Lankelma J, Leyva A, Pinedo HM. Peters GJ, et al. Among authors: van groeningen cj. Cancer Chemother Pharmacol. 1987;20(2):101-8. doi: 10.1007/BF00253962. Cancer Chemother Pharmacol. 1987. PMID: 3664929

10

Current chemotherapeutic possibilities in the treatment of colorectal cancer.

van Triest B, van Groeningen CJ, Pinedo HM. van Triest B, et al. Among authors: van groeningen cj. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1193-7. doi: 10.1016/0959-8049(95)00161-b. Eur J Cancer. 1995. PMID: 7577020 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters